AIM
SEM

Acrospire Investment Management’s Select Medical SEM Stock Holding History

Acrospire Investment Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,309
Closed -$27K – 1185
2017
Q2 		$27K Sell
3,309
-8,863
-73% -$66.5K 0.03% 1348
2017
Q1 		$88K Buy
12,172
+3,527
+41% +$25.6K 0.07% 412
2016
Q4 		$62K Sell
8,645
-6,877
-44% -$47.9K 0.03% 1259
2016
Q3 		$113K Buy
15,522
+5,383
+53% +$34.2K 0.08% 458
2016
Q2 		$59K Buy
+10,139
New +$67.2K 0.04% 928

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acrospire Investment Management's SEM Position: Q3 2017 in Review

Acrospire Investment Management sold out of Select Medical (SEM) in Q3 2017, closing a stake of 3,309 shares — an estimated $27K sold.

Acrospire Investment Management first reported a position in SEM in Q2 2016 and held it in 5 quarters. The position peaked at $113K in Q3 2016. 180 funds tracked by Wall St. Rank hold SEM as of Q3 2017.

  • Acrospire Investment Management reported no remaining Select Medical position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 3,309 Select Medical shares in Q3 2017, an estimated $27K.
  • Acrospire Investment Management first reported a position in Select Medical in Q2 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Select Medical position peaked at $113K in Q3 2016.
  • 180 funds tracked by Wall St. Rank held Select Medical as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.